Investigator-Initiated Research (IIR) and Collaborative Research Grants

About this program

Neurocrine Biosciences offers Investigator‑Initiated Research (IIR) and Collaborative Research Grants to external investigators, providing funding and/or supply of Neurocrine products to support investigator‑led studies that could advance scientific knowledge and improve patient care. Priority topics map to Neurocrine’s clinical programs, including valbenazine studies in tardive dyskinesia and Huntington’s disease with chorea (e.g., clinical impact, biomarkers, screening, real‑world outcomes) and crinecerfont research in congenital adrenal hyperplasia (e.g., management strategies, alternative biomarkers, transition of care, neuropsychiatric outcomes). Eligible applicants are qualified researchers responsible for the study design, implementation, conduct, and adherence to all institutional and regulatory requirements; interested investigators must submit an application and may contact studygrants@neurocrine.com for inquiries.